Haemophilus influenzae is an important pathogen in man. Encapsulated H. influenzae type b is a leading cause of bacteremia, pneumonia and meningitis in infancy in the United States. Unencapsulated or nontypable H. influenzae is an important cause of sepsis in the newborn and in certain immunocompromised patients and of infection in the middle ear and in the respiratory tract in adults and children. The goal of this proposed study is to define the molecular bases of the clearance of H. influenzae from the bloodstream. Previous studies indicate that this process of clearance depends upon receptor-mediated phagocytosis of these pathogens by fixed macrophages. Therefore, in the proposed work the interaction of H. influenzae with the macrophage will be examined. Since the understanding of how microbes interact with macrophages is largely based on work done with intracellular pathogens, the proposed study will concentrate on examining the role of specific receptors and ligands previously defined to mediate binding and ingestion of these organisms. This study, however, will begin to define how these mechanisms are used in defending the host from extracellular bacterial pathogens. The approach will be to determine (1) the specificity and physiology of the macrophage receptors which mediate direct binding of H. influenzae, (2) the bacterial surface components which act as ligands to these receptors, (3) the effects of antibody and serum complement as ligands for the interaction of H. influenzae with macrophages and (4) the potential for macrophage activation to modify this bacteria-macrophage interaction. This study will be conducted using in vitro culture systems for both murine and human macrohages along with in vivo study of H. influenzae bloodstream clearance in a murine model. This work is expected to define mechanisms critical in defending the immune and nonimmune host from infection due to H. influenzae. In doing so, it is expected that advances in designing effective prophylactic and therapeutic regimens aimed at these infections will be realized.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI030063-03
Application #
3455607
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1990-09-01
Project End
1995-07-31
Budget Start
1992-09-01
Budget End
1993-07-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Furuta, Yousuke; Komeno, Takashi; Nakamura, Takaaki (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449-463
Frey, Sharon E; Bernstein, David I; Brady, Rebecca C et al. (2015) Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. Vaccine 33:163-73
Kotloff, Karen L; Halasa, Natasha B; Harrison, Christopher J et al. (2014) Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children. Pediatr Infect Dis J 33:865-71
Gowen, Brian B; Jung, Kie-Hoon; Sefing, Eric J et al. (2014) Activity of a phenolic dibenzylsulfide against New World arenavirus infections. Antivir Chem Chemother 23:151-9
Smee, Donald F; Tarbet, E Bart; Furuta, Yousuke et al. (2013) Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice. Future Virol 8:1085-1094
Sefing, Eric J; Wong, Min-Hui; Larson, Deanna P et al. (2013) Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice. Virol J 10:221
Jackson, Lisa A; Chen, Wilbur H; Stapleton, Jack T et al. (2012) Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis 206:811-20
Camp, Jeremy V; Svensson, Thomas L; McBrayer, Alexis et al. (2012) De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets. PLoS One 7:e37104
Gowen, Brian B; Ennis, Jane; Sefing, Eric J et al. (2012) Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201). Antimicrob Agents Chemother 56:4168-74
Nguyen, Jack T; Smee, Donald F; Barnard, Dale L et al. (2012) Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PLoS One 7:e31006

Showing the most recent 10 out of 54 publications